newsfilter
← Latest News
ACCESS Newswire·

Integrated BioPharma Reports Results for its Quarter Ended March 31, 2022

HILLSIDE, NJ / ACCESSWIRE / May 12, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the fiscal quarter ended March 31, 2022. Revenue for the three-month period ended March 31, 2022 was $15.6 mil